BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2698296)

  • 1. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
    Mizuno Y
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic activation of azaheterocyclics induced dopaminergic toxicity: possible candidate neurotoxins underlying idiopathic Parkinson's disease].
    Matsubara K
    Nihon Hoigaku Zasshi; 1998 Oct; 52(5):301-5. PubMed ID: 10077975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
    Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural degeneration and the transport of neurotransmitters.
    Edwards RH
    Ann Neurol; 1993 Nov; 34(5):638-45. PubMed ID: 7902065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
    Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
    J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental model of Parkinson disease: mechanisms and anatomo- pathological characteristics of MPTP neurotoxicity].
    Herrero MT; Luquín MR; Obeso JA
    Arch Neurobiol (Madr); 1992; 55(4):175-82. PubMed ID: 1417423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Search for the cause of Parkinson's disease].
    Langston JW
    Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
    [No Abstract]   [Full Text] [Related]  

  • 10. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
    Desai VG; Feuers RJ; Hart RW; Ali SF
    Brain Res; 1996 Apr; 715(1-2):1-8. PubMed ID: 8739616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine.
    Boada J; Cutillas B; Roig T; Bermúdez J; Ambrosio S
    Biochem Biophys Res Commun; 2000 Feb; 268(3):916-20. PubMed ID: 10679305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo.
    Mizuno Y; Suzuki K; Sone N
    Adv Neurol; 1990; 53():197-200. PubMed ID: 2122644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain.
    Bachurin SO; Shevtzova EP; Lermontova NN; Serkova TP; Ramsay RR
    Neurotoxicology; 1996; 17(3-4):897-903. PubMed ID: 9086513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK; Mehta AK; Aley KO; Shukla VK
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parkinson's disease; etiology and animal model].
    Mizuno Y
    No To Shinkei; 1991 Aug; 43(8):703-11. PubMed ID: 1931253
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.
    Suzuki K; Mizuno Y; Yoshida M
    Neurochem Res; 1990 Jul; 15(7):705-10. PubMed ID: 1975653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y; Sone N; Saitoh T
    J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
    Suzuki K; Mizuno Y; Yoshida M
    Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.